Nuvation Bio Inc
NUVBLatest QuantConomy context for NUVB: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Nuvation Bio Inc
QuantConomy has a structured record for NUVB. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- NUVB
- Name
- Nuvation Bio Inc
- Coverage
- 3 market/data records
- Sources
- alpaca alphavantage fmp sec nasdaq
Recent signals for NUVB
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| corporate event financial obligation | neutral | 80 | Jul 6, 09:20 PM | NUVB filed 8-K: Direct Financial Obligation, Other Events - 2 material events - [very strong neutral signal] |
| corporate event material agreement | bullish | 95 | Jun 30, 09:50 PM | NUVB filed 8-K: Material Definitive Agreement, Termination of Material Agreement, Direct Financial Obligation - 4 material events - [very strong bullish signal] |
| insider trade executive trade | slightly bullish | 31 | Jun 24, 11:11 PM | Markel Stacy (CHIEF PEOPLE OFFICER) exercised options for NUVB shares ($0.17M) - 90,380 shares - [very weak slightly bullish signal] |
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| NUVB | NYSE | alpaca | Nuvation Bio Inc. |
| NUVB | NYSE | alphavantage | Nuvation Bio Inc - Class A |
| NUVB | NYSE | fmp | Nuvation Bio Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | exercise | 63,000 | $2.93 | $184,590 | 4 on EDGAR |
| Jun 23, 2026 | Markel Stacy | CHIEF PEOPLE OFFICER | exercise | 90,380 | $1.87 | $169,011 | 4 on EDGAR |
| Jun 23, 2026 | Sauvage Philippe | Chief Financial Officer | exercise | 47,668 | $2.17 | $103,440 | 4 on EDGAR |
| Jun 9, 2026 | Mashal Robert | Director | purchase | 25,000 | $4.73 | $118,250 | 4 on EDGAR |
| May 21, 2026 | Mashal Robert | Director | grant | 123,397 | — | — | 4 on EDGAR |
| May 21, 2026 | BLICKENSTAFF KIM D | Director | grant | 123,397 | — | — | 4 on EDGAR |
| May 21, 2026 | Bazemore Robert B | Director | grant | 123,397 | — | — | 4 on EDGAR |
| May 21, 2026 | FALBERG KATHRYN E | Director | grant | 123,397 | — | — | 4 on EDGAR |
| May 21, 2026 | Cui Xiangmin | Director | grant | 123,397 | — | — | 4 on EDGAR |
| May 21, 2026 | VERNON W ANTHONY | Director | grant | 123,397 | — | — | 4 on EDGAR |
| Apr 17, 2026 | Liu Dongfang | CHIEF MEDICAL OFFICER | exercise | 50,000 | $1.94 | $97,000 | 4 on EDGAR |
| Apr 17, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | exercise | 36,750 | $2.93 | $107,678 | 4 on EDGAR |
| Apr 6, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | exercise | 100,000 | $1.87 | $187,000 | 4 on EDGAR |
| Feb 27, 2026 | Makunje Moses | SEE REMARKS | grant | 50,761 | $0.00 | $0 | 4 on EDGAR |
| Feb 27, 2026 | Cui Xiangmin | Director | grant | 74,813 | — | — | 4 on EDGAR |
| Feb 27, 2026 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | grant | 748,130 | — | — | 4 on EDGAR |
| Feb 27, 2026 | Markel Stacy | CHIEF PEOPLE OFFICER | grant | 748,130 | — | — | 4 on EDGAR |
| Feb 27, 2026 | Sjogren Colleen | Chief Commercial Officer | grant | 748,130 | — | — | 4 on EDGAR |
| Feb 27, 2026 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | grant | 748,130 | — | — | 4 on EDGAR |
| Feb 27, 2026 | Sauvage Philippe | Chief Financial Officer | grant | 748,130 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query NUVB context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access